Related Experiment Video
Updated: Dec 17, 2025

Assessment of Maternal Vascular Remodeling During Pregnancy in the Mouse Uterus
Published on: December 5, 2015
Moyamoya syndrome related to systemic lupus erythematosus developing during pregnancy: a case-based review
Rika Tanaka1, Yasuhiro Shimojima2, Ken-Ichi Ueno1
1Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Abstract:
Moyamoya syndrome (MMS) is a chronic cerebrovascular disorder characterized by occlusion or stenosis of the internal carotid arteries with the formation of abnormal collateral vascular networks. Moreover, the development of MMS, which is a distinct category from "moyamoya disease," is attributed to the underlying disease, while some cases of MMS related to systemic lupus erythematosus (SLE) have been previously reported. Herein, we present the case of a 29-year-old Japanese woman with SLE in whom intracranial hemorrhage ascribable to MMS developed during pregnancy. Craniotomy was performed to remove hematoma, and prednisolone, tacrolimus, and hydroxychloroquine were consecutively administered. She ultimately achieved remission and childbearing without the relapse of cerebrovascular event. To our knowledge, this is the first report of MMS associated with SLE in pregnancy. Through reviewing published English articles and our case, it was suggested that the pathogenesis of SLE is implicated in the development of moyamoya vasculopathy leading to cerebrovascular events. Moreover, pregnancy may affect the bleeding from the fragile collateral vessel wall.
Insights
Moyamoya syndrome (MMS) in pregnancy is rare, especially when linked to systemic lupus erythematosus (SLE). This case highlights pregnancy
Area of Science:
- Neurology
- Rheumatology
- Obstetrics
Background:
- Moyamoya syndrome (MMS) is a chronic cerebrovascular condition.
- Systemic lupus erythematosus (SLE) can be an underlying cause of MMS.
- MMS during pregnancy presents unique challenges.
Observation:
- A 29-year-old Japanese woman with SLE developed intracranial hemorrhage due to MMS during pregnancy.
- The patient underwent craniotomy and received immunosuppressive therapy (prednisolone, tacrolimus, hydroxychloroquine).
Findings:
- This is the first reported case of MMS associated with SLE during pregnancy.
- The study suggests SLE pathogenesis may contribute to moyamoya vasculopathy.
- Pregnancy may increase bleeding risk from fragile collateral vessels in MMS.
Implications:
- Early diagnosis and management of MMS in pregnant SLE patients are crucial.
- Understanding the interplay between SLE, pregnancy, and MMS can guide treatment strategies.
- This case underscores the importance of multidisciplinary care for complex obstetric cases.
More Related Videos
07:50A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
05:44Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
Published on: October 13, 2023
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Mitral Valve Prolapse III: Nursing Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Nephrotic Syndrome I : Introduction
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease I: Introduction